Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: a quantitative review.

Quantitative review of the controlled treatment outcome literature for obsessive-compulsive disorder (OCD) showed that exposure with response prevention was highly effective in reducing OCD symptoms. Cognitive approaches were also found to be at least as effective as exposure procedures. It appears that both cognitive and exposure interventions involve some overlapping procedures and capitalize on similar mechanisms of change. Serotonergic medication, particularly clomipramine, also substantially reduced OCD symptoms. However, clomipramine may not be particularly superior to other serotonergic medication. The relationship between side effects and effect size in medication trials was explored.

[1]  S. Turner,et al.  Current status of pharmacological and behavioral treatment of obsessive-compulsive disorder , 1995 .

[2]  U. Feske,et al.  Cognitive behavioral versus exposure only treatment for social phobia: A meta-analysis , 1995 .

[3]  A. V. van Balkom,et al.  Cognitive therapy and exposure in vivo in the treatment of obsessive compulsive disorder. , 1995, Behaviour research and therapy.

[4]  P. van Oppen.  Cognitive Therapy for Obsessive-Compulsive Disorder , 2004, Behaviour research and therapy.

[5]  R. Bornstein,et al.  A Meta‐Analysis of Fluoxetine Outcome in the Treatment of Depression , 1994, The Journal of nervous and mental disease.

[6]  A. Rush,et al.  A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder. , 1994, Archives of general psychiatry.

[7]  A. Ellis.  Rational emotive behavior therapy approaches to obsessive-compulsive disorder (OCD) , 1994 .

[8]  C. McDougle,et al.  Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics. , 1994, Archives of general psychiatry.

[9]  J. Greist,et al.  Behavior therapy for obsessive compulsive disorder. , 1992, The Journal of clinical psychiatry.

[10]  P. Emmelkamp,et al.  The Irrational Beliefs Inventory (IBI): Development and psychometric evaluation , 1994 .

[11]  A. Balkom,et al.  A meta-analysis on the treatment of obsessive compulsive disorder: A comparison of antidepressants, behavior, and cognitive therapy , 1994 .

[12]  Dc Washington.  Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. , 1994 .

[13]  Mark W. Lipsey,et al.  The efficacy of psychological, educational, and behavioral treatment. Confirmation from meta-analysis. , 1993, The American psychologist.

[14]  C. McDougle,et al.  The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder. , 1993, Journal of clinical psychopharmacology.

[15]  A. McIntyre,et al.  A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder , 1993, European Neuropsychopharmacology.

[16]  S. Fisher,et al.  How Sound Is the Double-Blind Design for Evaluating Psychotropic Drugs? , 1993, The Journal of nervous and mental disease.

[17]  Allen P. Marks,et al.  A Comparison of Behavioral Group Therapy and Individual Behavior Therapy in Treating Obsessive-Compulsive Disorder , 1993, The Journal of nervous and mental disease.

[18]  E. Hollander,et al.  Comparison of clomipramine, alprazolam and placebo in the treatment of obsessive—compulsive disorder , 1992 .

[19]  A. Bulbena,et al.  Clomipramine versus Phenelzine in Obsessive–Compulsive Disorder , 1992, British Journal of Psychiatry.

[20]  R. Bornstein,et al.  A meta-analysis of antidepressant outcome under "blinder" conditions. , 1992, Journal of consulting and clinical psychology.

[21]  K. Kobak,et al.  A Computer-Administered Version of the Yale-Brown Obsessive-Compulsive Scale , 1992 .

[22]  Sara E. Quay,et al.  Short- and Long-Term Treatment of Obsessive-Compulsive Disorder with Fluvoxamine , 1992 .

[23]  D. Murphy,et al.  A double-blind, placebo controlled study of trazodone in patients with obsessive-compulsive disorder. , 1992, Journal of clinical psychopharmacology.

[24]  E. Smeraldi,et al.  Fluvoxamine vs clomipramine treatment in obsessive-compulsive disorder: A preliminary study , 1992 .

[25]  M. Jenike,et al.  Clomipramine in the treatment of patients with obsessive-compulsive disorder. The Clomipramine Collaborative Study Group. , 1991, Archives of general psychiatry.

[26]  D. Murphy,et al.  Controlled comparison of buspirone and clomipramine in obsessive-compulsive disorder. , 1991, The American journal of psychiatry.

[27]  P. Emmelkamp,et al.  Cognitive therapy with obsessive-compulsive disorder: a comparative evaluation. , 1991, Behaviour research and therapy.

[28]  D. Murphy,et al.  Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results. , 1990, Archives of general psychiatry.

[29]  J. Deveaugh-Geiss,et al.  Clomipramine in obsessive-compulsive disorder , 1990, Biological Psychiatry.

[30]  S. Hyman,et al.  A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory. , 1990, The American journal of psychiatry.

[31]  S. Olson,et al.  Clomipramine in Obsessive‐Compulsive Disorder: Clinical Response and Plasma Levels , 1990, Journal of clinical psychopharmacology.

[32]  M. Jenike,et al.  Sertraline in obsessive-compulsive disorder: a double-blind comparison with placebo. , 1990, The American journal of psychiatry.

[33]  J. Greist,et al.  Clomipramine and obsessive compulsive disorder: a placebo-controlled double-blind study of 32 patients. , 1990, The Journal of clinical psychiatry.

[34]  M. Jenike,et al.  Clomipramine versus Fluoxetine in Obsessive-Compulsive Disorder: A Retrospective Comparison of Side Effects and Efficacy , 1990, Journal of clinical psychopharmacology.

[35]  M. Jenike,et al.  Age of onset of major subtypes of obsessive—compulsive disorder , 1990 .

[36]  I. Marks,et al.  A controlled study of fluvoxamine and exposure in obsessive-compulsive disorder. , 1990, International clinical psychopharmacology.

[37]  M. Jenike,et al.  Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder. , 1990, Psychopharmacology bulletin.

[38]  W. Goodman,et al.  Clinical predictors of treatment response in obsessive compulsive disorder: exploratory analyses from multicenter trials of clomipramine. , 1990, Psychopharmacology bulletin.

[39]  P. Lachenbruch.  Statistical Power Analysis for the Behavioral Sciences (2nd ed.) , 1989 .

[40]  W. Goodman,et al.  The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. , 1989, Archives of general psychiatry.

[41]  M. Jenike,et al.  Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patients. , 1989, The American journal of psychiatry.

[42]  P. Salkovskis.  Cognitive-behavioural factors and the persistence of intrusive thoughts in obsessional problems. , 1989, Behaviour research and therapy.

[43]  W. Goodman,et al.  Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo. , 1989, Archives of general psychiatry.

[44]  S. Sorenson,et al.  The epidemiology of obsessive-compulsive disorder in five US communities. , 1988, Archives of general psychiatry.

[45]  P. Lelliott,et al.  Clomipramine, Self-exposure and Therapist-aided Exposure for Obsessive–Compulsive Rituals , 1988, British Journal of Psychiatry.

[46]  T. Perse.  Obsessive-compulsive disorder: a treatment review. , 1988, The Journal of clinical psychiatry.

[47]  J. Greist,et al.  Fluvoxamine treatment of obsessive-compulsive disorder. , 1987, The American journal of psychiatry.

[48]  D. Hadzi-Pavlovic,et al.  Behavior therapy and tricyclic medication in the treatment of obsessive-compulsive disorder: a quantitative review. , 1987, Journal of consulting and clinical psychology.

[49]  T. Insel,et al.  Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology , 1987, Biological Psychiatry.

[50]  M. Kozak,et al.  Imipramine and placebo in the treatment of obsessive-compulsives: their effect on depression and on obsessional symptoms. , 1987, Psychopharmacology bulletin.

[51]  M. Tsuang,et al.  Clinical characteristics and family history in DSM-III obsessive-compulsive disorder. , 1986, The American journal of psychiatry.

[52]  M. Kozak,et al.  Emotional processing of fear: exposure to corrective information. , 1986, Psychological bulletin.

[53]  T. Insel,et al.  Obsessive-compulsive disorder and serotonin: Is there a connection? , 1985, Biological Psychiatry.

[54]  S. Turner,et al.  Tricyclic antidepressants in obsessive-compulsive disorder: antiobsessional or antidepressant agents? II. , 1985, The American journal of psychiatry.

[55]  J. Volavka,et al.  Clomipramine and imipramine in obsessive-compulsive disorder , 1985, Psychiatry Research.

[56]  P. Salkovskis,et al.  Obsessional-compulsive problems: a cognitive-behavioural analysis. , 1985, Behaviour research and therapy.

[57]  E. Foa,et al.  Deliberate exposure and blocking of obsessive-compulsive rituals: Immediate and long-term effects. , 1984 .

[58]  T. Insel,et al.  Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline. , 1983, Archives of general psychiatry.

[59]  L. Hedges.  Estimation of effect size from a series of independent experiments. , 1982 .

[60]  G. Glass,et al.  Meta-analysis in social research , 1981 .

[61]  J. Ananth,et al.  Double-blind comparative study of clomipramine and amitriptyline in obsessive neurosis. , 1981, Progress in neuro-psychopharmacology.

[62]  M. Åsberg,et al.  Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial. , 1980, Archives of general psychiatry.

[63]  森住 宜司.  Foa, E. B. & Chambless, D. L., Habituation of Subjective Anxiety during Flooding in Imagery, Behavior Research and Therapy, 1978, Vol.16, 391-399 , 1980 .

[64]  P. Emmelkamp,et al.  Agoraphobia: a Follow-up Study Four Years After Treatment , 1979, British Journal of Psychiatry.

[65]  E. Foa,et al.  Continuous exposure and complete response prevention in the treatment of obsessive-compulsive neurosis , 1978 .

[66]  E. Foa,et al.  Habituation of subjective anxiety during flooding in imagery. , 1978, Behaviour research and therapy.

[67]  A. Hackmann,et al.  A comparison of flooding and thought stopping in the treatment of obsessional neurosis. , 1975, Behaviour research and therapy.

[68]  A. Beck.  Cognitive therapy and the emotional disorders: A. T. Beck , 1987, British Journal of Psychiatry.